Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes. (Q45875009)
Jump to navigation
Jump to search
scientific article published on 9 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes. |
scientific article published on 9 November 2011 |
Statements
Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes (English)
Myriam Jean
Mohamad Alameh
Diogo De Jesus
Marc Thibault
Marc Lavertu
Monica Nelea
Abderrazzak Merzouki